Navigation Links
VetStem Biopharma is Pleased to Share the Success Story of Jack, a Great Pyrenees who was Treated with Stem Cell Therapy by Dr. Andrea Hayes

Like many large breed dogs, Jack, a Great Pyrenees, began showing symptoms of joint disease very early on. Before he was a year old, his mom, Rebecca, noticed he was slow to get up and knew something was not quite right. She had him examined by her veterinarian and her suspicions were confirmed: Jack had bilateral hip dysplasia, a congenital condition affecting the formation of the hip joints. Left untreated, hip dysplasia will result in arthritis and pain in the joint. Rebecca realized the severity of the situation when, upon entering a pet store, Jack’s legs splayed out on the white, slippery floor and he yelped. She knew something had to be done.    

Jack’s veterinarian, Dr. Andrea Hayes of Boone Animal Hospital, gave Rebecca a few options for treatment. One option was total hip replacement, which is an invasive and expensive surgical procedure. As a second option, Dr. Hayes suggested treatment with VetStem Regenerative Cell Therapy. After weighing her options, Rebecca decided to move forward with stem cell therapy.

Jack received his initial round of stem cell injections back in 2014 when he was around seven months old. Jack underwent a minimally invasive procedure in which fat tissue was collected from beneath the skin around his rib cage. The tissue was aseptically packaged and sent to the VetStem laboratory in Poway, California. VetStem lab technicians processed the fat to concentrate and extract the stem cells and created injectable doses of Jack’s own stem and regenerative cells. After quality checks were performed, the doses were shipped back to Dr. Hayes who received and injected them approximately 48 hours after the initial fat collection. Jack received an injection into each hip and intravenously.

Approximately nine months after his initial round of injections, Rebecca reported that Jack was getting around much better. According to Rebecca he was a whole new dog. He was able to walk on slippery floors and run and hop around the yard. Though he was still stiff after playing too hard or after lying down for a long while, Rebecca believes he would not have survived much longer had he not received stem cell therapy.

Fast forward nearly four years to January of 2018 when Jack received his second round of injections. Rebecca had maintained Jack’s stem cell bank over the years so Dr. Hayes was able to request recovery and preparation of Jack’s stored stem cells, rather than performing another fat collection procedure on him. This time, he received an injection in his left elbow, left hip, and intravenously. Approximately four months after the injections, Rebecca reported that Jack was doing well. Though occasionally stiff when he gets up, Rebecca said he does his stretches and is good to go. We recently checked in with Rebecca and she reported that Jack is “still on the move.”

Stem cells are regenerative cells that can differentiate into many tissue types, reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. In a peer-reviewed study of dogs with chronic osteoarthritis of the hip joint, it was found that stem cells reduced lameness and pain.

About Andrea Hayes, VMD, DACVS
Dr. Andrea Hayes received her Veterinary Medical Degree from the University of Pennsylvania. She completed a joint surgical residency at the Cummings School of Veterinary Medicine at Tufts and Angell Animal Medical Center in Massachusetts. Dr. Hayes achieved her dream of helping dogs and cats by becoming a Board-Certified Surgeon specializing in orthopedics in 1996. Dr. Hayes has been VetStem Credentialed since 2008.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related biology news :

1. VetStem Biopharma is Pleased to Share the Success Story of Sam Who was Treated with Stem Cell Therapy by Dr. Lucy Roberts at Animal Medical Center of Tuscaloosa
2. Labrador Retriever Gets Back to Playing Fetch After Receiving VetStem Regenerative Stem Cell Therapy
3. VetStem Biopharma is Pleased to Share the Success Story of Mandy, who was Treated with Stem Cell Therapy by Dr. Jerrold Bausman at VCA Vet Specialists of the Valley
4. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
5. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
6. First drug candidate from NIH program acquired by biopharmaceutical company
7. Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference
8. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
9. Dr. Deborah French Shares Insight on Validation of Clinical LC-MS/MS in Educational Webinar
10. Biomass Boiler Market Boilers - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
11. 43% Would Share Biometric Data With Health Insurance Company
Post Your Comments:
(Date:6/5/2020)... ... 04, 2020 , ... Murrieta Genomics has announced that its wholly ... sample preparation for Next Generation Genomic Sequencing (NGS) . This is the third ... of sample preparation. , “I have been at the bench for over 20 years,” ...
(Date:5/28/2020)... , ... May 27, 2020 , ... CrucialTrak, a global ... with New Jersey-based Critical Environments Group (CEG) to market and sell its complete line ... data center and IT environment infrastructure optimization solutions . , Brett Mason, ...
(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is in advanced development of ... that causes COVID-19. , The LamPORE assay is designed to be rapid, ... very large numbers of samples. Hardware and reagents sit outside current, squeezed supply ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... data insights, today announced that the launch of a new clinical ... data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast ... bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus ... Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just ...
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace project ... to join forces to radically prolong life and find a way (medicine or technology) ... This project was supported by various scientists from all over the world, doctors, and ...
(Date:6/3/2020)... ... June 03, 2020 , ... ... applications of biofeedback. In the next installment, Dr. Inna Khazan will discuss the ... learn to bring their attention to the feelings, thoughts, and emotions they are ...
Breaking Biology Technology: